CRISPR Therapeutics
CRSP
#3489
Rank
A$4.63 B
Marketcap
$54.04
Share price
-0.03%
Change (1 day)
-45.05%
Change (1 year)

Earnings for CRISPR Therapeutics (CRSP)

Earnings in 2024 (TTM): -A$0.55 Billion

According to CRISPR Therapeutics's latest financial reports the company's current earnings are A$35 Million. a decrease over its 2023 earnings that were of -A$0.25 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for CRISPR Therapeutics from 2016 to 2024

Annual earnings

Year Earnings Change
2024 -A$0.61 Billion140.62%
2023 -A$0.25 Billion-76.83%
2022 -A$1.08 Billion-271.4%
2021 A$0.62 B-209.04%
2020 -A$0.58 Billion-617.12%
2019 A$0.11 B-140.93%
2018 -A$0.28 Billion146.86%
2017 -A$0.12 Billion193.19%
2016 -A$37.61 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-A$0.24 Billion-60.60%๐Ÿ‡บ๐Ÿ‡ธ USA